Savara Inc Line of Credit Facility, Interest Rate During Period
Savara Inc (SVRA) reported Line of Credit Facility, Interest Rate During Period of 8.95% for the 12-month period ending 2015-12-31, per its 10-Q filed 2017-05-09.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityInterestRateDuringPeriod · last filed 2017-05-09
| Period end | Line of Credit Facility, Interest Rate During Period 0 month | Line of Credit Facility, Interest Rate During Period 12 month |
|---|---|---|
| 2015-12-31 | 8.95% 10-Q · filed 2017-05-09 | |
| 2015-08-11 | 8.95% 10-Q · filed 2016-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B |